
What happens when a Nasdaq-listed pharmaceutical giant steps into the uncharted waters of cryptocurrency with a multimillion-dollar splash? Artelo Biosciences has ignited a firestorm in both the biotech and blockchain worlds by becoming the first publicly traded company of its kind to adopt Solana (SOL) into its corporate treasury. With a staggering $9.475 million investment, this groundbreaking decision has propelled










